Editor in Chief Dr KK Aggarwal, Padma Shri Awardee                                                                           Dated:21st September,2019

Most physicians do not screen for social determinants of health

Findings of a cross-sectional study published Sept. 18, 2019 in JAMA Network Open suggest that most US physician practices and hospitals do not screen patients for all 5 key social needs (food insecurity, housing instability, utility needs, transportation needs, and experience with interpersonal violence) associated with health outcomes. In the study, approximately 24% of hospitals and 16% of physician practices reported screening for all five social needs. Practices that serve disadvantaged patients report higher screening rates.


2-Km Walk Test and 6-Minute Walk Test
Join the campaign “Walk 2 km on 2nd October”

The year 2019 is the year for wellness and fitness. If you can walk 2 km without symptoms or 500 meters in six minutes, you are cardiac fit.

Heart Care Foundation is inviting members of the public in Delhi to join the campaign “Walk 2 km on 2nd October”at various locations. During the walk, you can also look for plastic littered on the roads and remove them to highlight the fact that plastic is banned in Delhi.

The event is being organised in association with Delhi Medical Association, Sports Authority of India and many NGOs. ....read more


Mera Asia Mahan 11: A Prescription for Gandhigiri (Gandhism)
Mahatma Gandhi taught four basic principles of satya (truthfulness), ahimsa (non-violence), sarvodaya (welfare for all) and Satyagraha.

Gandhigiri (Gandhism) or the Gandhian principles always united the common man.

The word Dharma means to hold together. All the above four principles can hold people together and hence form the backbone of dharma.

The Yoga-shastras propagate truthfulness as one of the main components for living a disciplined life or to start yoga.

Satya means oneness in your thoughts, speech and actions. ....read more


The spiritual prescription "I am sorry"
Two hardest words for a doctor to say: "I’m sorry." Most defence lawyers counsel doctors to not apologize to patients. Their view is that if you say you’re sorry for something, you are implicitly taking some degree of responsibility for whatever has happened. In other words, you are pleading guilty. The complainant’s lawyers may use a doctor’s apology to the maximum extent possible to show the doctor knew what they did was wrong. The usual approach is to deny and defend. But, ....read more

Healthcare News Monitor

Guidelines out for empanelled hospitals to get bronze certified
ET Healthworld -ANI: Priyanka Sharma

New Delhi: To ensure patient safety and quality of healthcare treatment, the National Health Authority (NHA) has formulated guidelines for the Pradhan Mantri Jan Arogya Yojana (AB-PMJAY), known as Ayushman Bharat- for empanelled hospitals to get 'Bronze Certification'. NHA, which is the implementing body of AB-PMJAY, has stated that the hospitals empanelled with the healthcare scheme and not holding any accreditation or certification from any recognized body like NQAS, NABH, and JCI, should apply for bronze certification. This list of guidelines include- strengthening infrastructure and human resource, appropriate space for ambulance in hospital for patient movement, proper lighting facility inside and outside hospital; medical instruments and equipment requirement and maintenance; fire-fighting equipment and basic amenities like safe drinking water area, hygiene canteen and suitable toilets for men and women among others. Confirming the development, CEO of National Health Authority Dr Indu Bhushan stated, "This is a push towards hospitals for quality and standard healthcare. It will give ratings to the hospitals as per their quality standards. If they will have poor ratings, hospitals will have to improve their medical facilities. These guidelines have been framed in collaboration with Quality Council of India."

Europe, Canada start recall of Zantac drug versions after carcinogen scare
The Hindu Business Line

Drugmakers and global public-health regulators are taking steps to remove supplies of a popular heartburn medication that may have become tainted with a cancer-causing agent from the market. Novartis AG’s Sandoz unit said on Wednesday that it was halting worldwide distribution of generic versions of the stomach drug Zantac, just days after regulators in the US and Europe began investigating the discovery of a likely human carcinogen called NDMA, or N-Nitrosodimethylamine, in the medications. Some versions of Zantac, which is also known by the generic name ranitidine, have also been recalled in Europe and Canada as well. The moves are the latest in a series of actions aimed at getting drugs tainted with potentially deadly contaminants off pharmacy shelves. Since last year, the US Food and Drug Administration (FDA) has been overseeing a recall of a type of generic blood-pressure pills that originated in China and India and were contaminated with NDMA. On Friday, the FDA and Europe’s top drug regulator said that they were examining NDMA levels in Zantac and its generic forms and whether they pose any risk to patients. Ranitidine is taken by millions of people worldwide to treat gastrointestinal disorders and discomfort.

Probing presence of carcinogenic impurities in high BP drugs: DCGI
ET Healthworld

Following a spate of recalls of drugs containing sartans with carcinogenic impurities, the Drug Controller General of India is probing whether these hypertension and heart failure drugs, particularly, have impurities that may be carcinogenic, DCGI VG Somani said here on Thursday. Several lots of drugs containing key ingredient Valsartan were recalled voluntarily by Indian and global generics makers, including Aurobindo Pharma, after traces of impurity N-Nitrosodimethylamine (NDMA) or N-Nitrosodiethylamine (NDEA) were found. “That (carcinogenic impurities) was a batch specific phenomena. We are looking at it and we are investigating it. We will take appropriate decision on whether to accept it as a risk, whether to take some action on prescribing the product or whether to ban the product...we have a subject expert committee, we have chemical experts, we are going through all the things,” DCGI VG Somani told newspersons on the sidelines of the two-day International Regulators Meet organised by Pharmaceuticals Export Promotion Council of India (Pharmexcil) here. Somani said as per his understanding the impurities were not found during the initial approval process of the product (Valsartan) and were noticed when the final product came out.

Drug Controller General of India says all regulatory approvals to go online for transparency
The Hindu Business Line

Also working on regulatory convergence - All regulatory approvals from Drug Controller General of India (DCGI) will go completely online to ensure transparency to global as well domestic players, according to V G Somani, DCGI. He was speaking to newspersons on the sidelines of a two-day international regulators meet organised by the Pharmaceutical Exports Promotion Council of India (Pharmexcil) which began here on Thursday. "The approval process is partially online as of now but will go fully transparent except for some procedures like testing over next one to two years as we need some time to validate IT solutions to be used. With the entire world can believe us more,’’ Somani added. USFDA When asked on increasing number of warning letters to Indian drug makers from the US Food and Drug Administration (USFDA) and recalls of few drugs, DCGI said: "The US has the right to do whatever they want to do. We see it a customer as well as regulator and our job is to satisfy them fully on all counts.’’ "However, a warning or a recall from the USFDA does not mean that it will be followed by all other counties like Europe which also buy Indian drugs,’’ he said adding that sometimes it only creates `panic’.

Jaipur: Two hosps to be honoured for quality services
ET Healthworld

Jaipur: Competition among hospitals for procuring national certification for quality is heating up. Jalore’s district hospital will be rewarded in Delhi for assuring quality in treatment on October 2. It will get Rs 10,000 per bed. Next in race is Beawar’s district hospital. Beawar’s district hospital will also be felicitated for quality services. A team from the Centre will inspect the hospital in Beawar during September 26-28. If it passes the inspection, it will get Rs 10,000 per bed, of which 75% will be spent on the hospital and 25% will be distributed among the workers. The hospitals are now keeping their premises clean and also providing more facilities to the patients. “We have constructed a separate drug distribution counter so that pregnant women get the medicines easily and don’t have to walk long distances,” said an official at Beawar district hospital.